bianet

Freedom of Expression Panel: The Revised 301 Does Not Please Anyone

The Heinrich Böll Foundation organizes a panel about the freedom of expression in Turkey after the revision of article 301. Expressing different opinions, the participants agree that the revision has ...
Medindia

Data from FREEDOM-301 Study for LEVADEX(TM) Orally Inhaled Migraine Drug Published in 'Headache'

MOUNTAIN VIEW, Calif., April 7, 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the publication of results from the Phase 3 FREEDOM-301 study of LEVADEX(TM) orally inhaled migraine drug ...
Finanznachrichten

MAP Pharmaceuticals to Report Additional Subpopulation Data From FREEDOM-301 Trial at the Annual Meeting of the American Academy of Neurology

MOUNTAIN VIEW, Calif., April 7 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. today announced the Company will present additional post-hoc analyses from the ...
FierceBiotech

MAP Pharmaceuticals Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle and in Pati

MAP Pharmaceuticals Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle and in Patients with Concomitant Asthma FREEDOM-301 Analyses to be Presented at the ...
Science Daily

Novel, Orally Inhaled Migraine Therapy Is Effective, Study Shows

A new study shows an investigational, orally-inhaled therapy is effective in treating migraines. The multi-center, phase three FREEDOM-301 trial for the orally-inhaled migraine therapy, LEVADEX, shows ...